Hwang Yun Kyung, Kim Eosu, Kim Yong Bum, Kim Yong Wook, Nam Chung Mo, Cho Seung-Hun, Kim HyangHee
Graduate Program in Speech and Language Pathology, Yonsei University, Seoul, South Korea.
Dement Geriatr Cogn Disord. 2017;44(3-4):171-181. doi: 10.1159/000479149. Epub 2017 Sep 5.
Naming difficulties have recently garnered more interest in elderly individuals with mild cognitive impairment (MCI). We anticipate that naming tests with the consideration of response time can provide more informative and distinct neuropsychological profiles of individuals with MCI.
Naming tests were administered to 76 elderly individuals with MCI and 149 healthy elderly (HE). We analyzed the impact of MCI on naming performance and occurrence of "delayed" response. We also validated the predictive power of naming tests with a time-constrained scoring system.
MCI participants performed poorer on the noun naming test than HE participants (p = 0.014). MCI was significantly associated with the occurrence of "delayed" response on the noun (odds ratio [OR] = 3.57; 95% confidence interval [CI] = 1.78-7.17) and verb naming tests (OR = 4.66; 95% CI = 2.07-10.46). The time-constrained naming scores were significantly better able to distinguish the MCI from the HE group than the conventional spontaneous naming score on both the noun (p < 0.001) and verb (p = 0.002) naming tests.
Our findings broaden the knowledge related to the naming ability in individuals with MCI, with respect to the response time. We also confirmed the validity of the naming tests by applying the "delayed" responses as supplementary assessments in the diagnosis of MCI.
命名困难最近在轻度认知障碍(MCI)的老年人中引起了更多关注。我们预计,考虑反应时间的命名测试可以为MCI患者提供更丰富、独特的神经心理学特征。
对76名患有MCI的老年人和149名健康老年人(HE)进行命名测试。我们分析了MCI对命名表现和“延迟”反应发生情况的影响。我们还通过时间限制评分系统验证了命名测试的预测能力。
MCI参与者在名词命名测试中的表现比HE参与者差(p = 0.014)。MCI与名词(优势比[OR] = 3.57;95%置信区间[CI] = 1.78 - 7.17)和动词命名测试中“延迟”反应的发生显著相关(OR = 4.66;95% CI = 2.07 - 10.46)。在名词(p < 0.001)和动词(p = 0.002)命名测试中,时间限制命名分数比传统的自发命名分数更能显著区分MCI组和HE组。
我们的研究结果拓宽了关于MCI患者命名能力与反应时间相关的知识。我们还通过将“延迟”反应作为MCI诊断的补充评估,证实了命名测试的有效性。